Page last updated: 2024-10-28

hydralazine and Diabetes Insipidus

hydralazine has been researched along with Diabetes Insipidus in 1 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Diabetes Insipidus: A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gussin, RZ1
Stokey, EH1
Ronsberg, MA1
Malone, LC1
Cummings, JR1

Other Studies

1 other study available for hydralazine and Diabetes Insipidus

ArticleYear
The effect of guancydine on fluid and electrolyte excretion: a comparison with hydralazine and reserpine.
    Archives internationales de pharmacodynamie et de therapie, 1971, Volume: 192, Issue:1

    Topics: Adrenal Glands; Aldosterone; Animals; Antihypertensive Agents; Diabetes Insipidus; Diuresis; Dogs; F

1971